UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ildong Hyaltech to export HA filler to Brazil
Ildong Hyaltech, a subsidiary of Ildong Pharmaceutical, said Thursday that ...
by Lee Han-soo
|
2018-11-08 15:16
라인
Dong-A ST’s athlete’s foot treatment exceeds annual sales of ₩10 billion
Dong-A ST said Thursday that Jublia, a toenail fungal treatment, has surpas...
by Lee Han-soo
|
2018-11-08 15:16
라인
Well Marker Bio raises ₩28 billion for anticancer drug development
Anticancer treatment developer Well Marker Bio said it has completed the so...
by Lee Hye-seon
|
2018-11-08 15:10
라인
Koreas to run pilot program to exchange info on infectious diseases
South and North Korea agreed to operate a pilot program to exchange informa...
by Kwak Sung-sun
|
2018-11-08 14:26
라인
UK expert slams ‘study on miniscalpel acupuncture efficacy’ as maxi-nonsense
A study on miniscalpel acupuncture conducted by an Oriental medical college...
by Song Soo-youn
|
2018-11-08 11:15
라인
Lunit prepares to enlist on KOSDAQ by 2020
Lunit said Wednesday that it has started preparing to go public in the KOSD...
by Lee Han-soo
|
2018-11-07 16:48
라인
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon
|
2018-11-07 16:07
라인
‘Korea fighting losing battle against antimicrobial resistance’
The threat of antimicrobial resistance (AMR) is spreading rapidly, and Kore...
by Lee Han-soo
|
2018-11-07 16:07
라인
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo
|
2018-11-07 16:06
라인
Two Koreas discuss jointly blocking infectious diseases
Health authorities from South and North Korea met on Wednesday, 11 years af...
by Kwak Sung-sun
|
2018-11-07 15:00
라인
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon
|
2018-11-07 14:58
라인
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo
|
2018-11-07 12:26
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun
|
2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon
|
2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun
|
2018-11-06 15:41
라인
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo
|
2018-11-06 11:09
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon
|
2018-11-06 11:06
라인
Samsung BioLogics to complete Biogen’s call option
Samsung BioLogics posted Tuesday that the transfer of assets related to Sam...
by Lee Han-soo
|
2018-11-06 10:45
라인
SMC completes 20 cases of artificial heart transplant
Samsung Medical Center said Monday that it has become the first local hospi...
by Lee Han-soo
|
2018-11-06 10:44
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun
|
2018-11-05 16:32
-
이전
171
172
173
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top